Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Non-Current Deffered Revenue (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Non-Current Deffered Revenue for 16 consecutive years, with $51.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 9.49% to $51.0 million in Q4 2025 year-over-year; TTM through Nov 2025 was $51.0 million, a 9.49% increase, with the full-year FY2025 number at $51.0 million, up 9.49% from a year prior.
  • Non-Current Deffered Revenue was $51.0 million for Q4 2025 at Cryo Cell International, up from $49.8 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $51.0 million in Q4 2025 to a low of $28.0 million in Q1 2021.
  • A 5-year average of $39.4 million and a median of $39.3 million in 2023 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: rose 16.01% in 2021, then increased 9.49% in 2025.
  • Cryo Cell International's Non-Current Deffered Revenue stood at $31.3 million in 2021, then grew by 15.11% to $36.0 million in 2022, then increased by 14.41% to $41.2 million in 2023, then grew by 13.04% to $46.6 million in 2024, then increased by 9.49% to $51.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Non-Current Deffered Revenue are $51.0 million (Q4 2025), $49.8 million (Q3 2025), and $48.8 million (Q2 2025).